Skip to Content

Agilent Technologies Inc A Stock Quote

| Rating as of

Morningstar‘s Stock Analysis A

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Agilent's Wide Moat Remains Intact in Life Sciences

Julie Utterback, CFA Senior Equity Analyst

Business Strategy and Outlook

| Julie Utterback, CFA |

After its spin-out from Hewlett Packard in 1999 and its divestiture of the electronic measurement business (Keysight Technologies) in November 2014, Agilent focuses on providing tools to analyze the structural properties of various chemicals, molecules, and cells. Agilent is one of the leading providers of chromatography and mass spectrometry tools, which have applications in a variety of end markets, including the healthcare, chemical, energy, food, and environmental fields. While healthcare-related applications, including clinical diagnostics, remain Agilent’s largest end market, Agilent generates about half of its sales from nonhealthcare fields.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics A

Company Profile A

Business Description

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.

Contact
5301 Stevens Creek Boulevard
Santa Clara, CA, 95051
T +1 800 227-9770
Industry Diagnostics & Research
Most Recent Earnings Apr 30, 2022
Fiscal Year End Oct 31, 2022
Stock Type Classic Growth
Employees 17,400

Related News A